{"organizations": [], "uuid": "4351a771d53c659bc5bc67f05700d63c7c38422e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180308.html", "section_title": "Archive News &amp; Video for Thursday, 08 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-redwood-pharma-acquires-intellectu/brief-redwood-pharma-acquires-intellectual-property-rights-idUSASM000K8H", "country": "US", "domain_rank": 408, "title": "BRIEF-Redwood Pharma Acquires Intellectual Property Rights", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.254, "site_type": "news", "published": "2018-03-08T23:57:00.000+02:00", "replies_count": 0, "uuid": "4351a771d53c659bc5bc67f05700d63c7c38422e"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-redwood-pharma-acquires-intellectu/brief-redwood-pharma-acquires-intellectual-property-rights-idUSASM000K8H", "ord_in_thread": 0, "title": "BRIEF-Redwood Pharma Acquires Intellectual Property Rights", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "redwood pharma ab", "sentiment": "negative"}, {"name": "brief-redwood pharma acquires intellectual property rights march", "sentiment": "negative"}, {"name": "redwood pharma", "sentiment": "none"}, {"name": "thomson reuters trust principles", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 8 (Reuters) - Redwood Pharma Ab:\n* REDWOOD PHARMA ACQUIRES INTELLECTUAL PROPERTY RIGHTS * HAS ENTERED INTO AN AGREEMENT REGARDING ACQUISITION OF CERTAIN PATENT AND PATENT APPLICATIONS\n* PAYMENT WILL OCCUR THROUGH ISSUANCE OF 525,000 SHARES BY REDWOOD PHARMA.\n* REDWOOD ACQUIRES PATENT AND PATENT APPLICATIONS, AS WELL AS DATA, FOR A CONSIDERATION OF SEK 5.1 MILLION Source text for Eikon: Further company coverage: (Gdynia Newsroom)\nOur Standards: The Thomson Reuters Trust Principles.", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-08T23:57:00.000+02:00", "crawled": "2018-03-09T14:52:10.016+02:00", "highlightTitle": ""}